News
PBSV
0.565
NaN%
--
Weekly Report: what happened at PBSV last week (0615-0619)?
Weekly Report · 1d ago
Pharma-Bio Serv reports Q2 results
Seeking Alpha · 06/15 21:05
Pharma-Bio Serv FY26 Q2 net income more than doubled to $233,000; revenue rises 11.83% to $2.7 million
PUBT · 06/15 20:50
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026
Barchart · 06/15 16:00
Weekly Report: what happened at PBSV last week (0608-0612)?
Weekly Report · 06/15 10:06
Weekly Report: what happened at PBSV last week (0601-0605)?
Weekly Report · 06/08 10:03
Weekly Report: what happened at PBSV last week (0525-0529)?
Weekly Report · 06/01 10:06
Weekly Report: what happened at PBSV last week (0518-0522)?
Weekly Report · 05/25 10:09
Weekly Report: what happened at PBSV last week (0511-0515)?
Weekly Report · 05/18 10:09
Pharma-Bio Serv shareholders elected Irving Wiesen as Class I director
PUBT · 05/15 21:06
Weekly Report: what happened at PBSV last week (0504-0508)?
Weekly Report · 05/11 10:07
Weekly Report: what happened at PBSV last week (0427-0501)?
Weekly Report · 05/04 10:05
Weekly Report: what happened at PBSV last week (0420-0424)?
Weekly Report · 04/27 10:07
Weekly Report: what happened at PBSV last week (0413-0417)?
Weekly Report · 04/20 10:03
Pharma-Bio Serv publishes 2025 annual report on Form 10-K
PUBT · 04/16 20:21
Pharma-Bio Serv announces annual shareholder meeting
PUBT · 04/16 20:19
Weekly Report: what happened at PBSV last week (0406-0410)?
Weekly Report · 04/13 10:07
Weekly Report: what happened at PBSV last week (0330-0403)?
Weekly Report · 04/06 10:07
Weekly Report: what happened at PBSV last week (0323-0327)?
Weekly Report · 03/30 10:07
Weekly Report: what happened at PBSV last week (0316-0320)?
Weekly Report · 03/23 10:03
More
Webull provides a variety of real-time PBSV stock news. You can receive the latest news about Pharma-Bio Serv Inc through multiple platforms. This information may help you make smarter investment decisions.
About PBSV
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company services the Puerto Rico, United States, Europe and Latin America markets. The Company's core business is Food and Drug Administration (FDA) and international agencies regulatory compliance consulting related services. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetics and food industries, and allied products companies. The Company's services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company operates in three reportable business segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, and Europe technical compliance consulting. The Company markets its services with a presence in industry trade shows, professional conventions, industry publications and company-provided seminars to the industry.